BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE
This analytical paper presents the key information on the mechanism of action of a direct thrombin inhibitor – bivalirudin. The difference between bivalirudin and unfractionated or low molecular weight heparins, as well as fondaparinux, in terms of the mechanism of action, pharmacokinetics, and phar...
Saved in:
| Main Author: | O. V. Averkov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2012-06-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1236 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reduced-dose of bivalirudin (without the post-procedure infusion) in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention
by: Qian Wang, et al.
Published: (2024-12-01) -
The efficacy and safety of bivalirudin and heparin in patients with acute coronary syndrome: a systematic review and meta-analysis
by: You Zhai, et al.
Published: (2025-02-01) -
Parenteral anticoagulants in the treatment of acute coronary syndrome: what modern clinical guidelines say
by: I. S. Yavelov
Published: (2022-06-01) -
IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: S. D. Chevgun, et al.
Published: (2017-12-01) -
Critical endpoints in dynamic follow-up of anemia patients with percutaneous coronary intervention for acute coronary syndrome
by: Margarita A. Simonyan, et al.
Published: (2023-12-01)